Tirzepatide Offers New Possibilities in Obstructive Sleep Apnea Management

With obstructive sleep apnea (OSA) becoming increasingly recognized for its systemic impact, a new development in pharmacotherapy may reshape how clinicians across specialties approach its management. A recent review discusses the implications of tirzepatide—a GLP-1 receptor agonist now approved by the FDA for weight loss in adults with OSA—and what it means for oral health professionals. OSA is marked by repeated collapse of the upper airway during sleep, leading to breathing disruptions, oxygen desaturation, and long-term health risks such as hypertension, cardiovascular disease, and stroke. Weight is a key modifiable risk factor, and many treatment approaches center around weight reduction, alongside oral appliances, surgery, and CPAP therapy. In 2024, the FDA approved tirzepatide (Zepbound, Lilly) for weight management in patients with OSA. Originally used for diabetes and obesity, the medication has shown promise in reducing apnea severity by facilitating significant weight loss. The authors of this review highlight its emerging role in multidisciplinary care for OSA and how it intersects with oral health delivery. While dentists are not prescribers of tirzepatide, their involvement in early OSA screening is vital. Clinical signs—such as narrow arches, retrognathic jaws, tongue scalloping, and bruxism—can signal underlying airway compromise. Dentists also provide custom oral appliance therapy and coordinate with sleep specialists for diagnosis and ongoing care. Interestingly, the systemic benefits of tirzepatide may also have secondary effects on oral health. By improving glycemic control and reducing inflammation, it could positively influence periodontal therapy outcomes, orthodontic planning, and even implant success Tirzepatide represents not just a tool for physicians but a potential adjunctive influence on oral treatment planning. As the boundaries between systemic and oral health narrow, dental professionals are increasingly part of the solution—identifying, referring, and managing OSA-related concerns in daily practice. Source: The Journal of the American Dental Association